Business

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it will be hosting a booth at the 17th Annual Next Generation Dx Summit, held virtually and in-person at the Capital Hilton in Washington, D.C. on August 18-20, 2025.

articleCo-diagnostics, Inc.August 18, 20252/company/co-diagnostics-inc/news/co-diagnostics-inc-host-booth-133000997
Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

About this update from Co-diagnostics, Inc.

[{"type":"text","content":"SALT LAKE CITY, Aug. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it will be hosting a booth at the 17th Annual Next Generation Dx Summit, held virtually and in-person at the Capital Hilton in Washington, D.C. on August 18-20, 2025.","length":443,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Co-Diagnostics)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Co-Diagnostics)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":184,"url":"https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_YQ2JYyHRV7RlBcYGBsF.Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTMyNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","width":400,"height":184}},"href":"https://mma.prnewswire.com/media/1856437/Co_Diagnostics_New_Logo_v1.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Cambridge Healthtech Institute's Next Generation Dx Summit is described as the nexus for international thought leaders to network and discuss diagnostic advancement and technology innovation, and offers a valuable window into how point-of-care, decentralized testing, infectious disease, liquid biopsy and companion diagnostics are improving the standard of care in the diagnostics industry.","length":395,"tagName":"p"},{"type":"text","content":"Attendees are invited to visit the Company at Booth #12 to learn more about the Co-Dx Logix SmartĀ® suite of clinical laboratory solutions, as well as the upcoming Co-Dx PCR diagnostics platform* and the pipeline of upper respiratory, tuberculosis and HPV tests, all of which the Company is anticipating entering into clinical evaluations during 2025.","length":350,"tagName":"p"},{"type":"text","content":"To learn more about the summit, including in-person and virtual registration details, please visit https://www.nextgenerationdx.com.","length":132,"tagName":"p"},{"type":"text","content":"Company travel and conference attendance is made possible due in part to a grant from World Trade Center Utah, a member of the World Trade Centers Association founded in 2006 with ...

More updates from Co-diagnostics, Inc.

molecular diagnosticsCo-Diagnostics, Inc.Dx SummitThe Companymolecular diagnostic testsCambridge Healthtech InstituteCompany travel